New things are always developing at Children's Mercy Hospitals and Clinics. This page is a resource for updates about new research studies, clinical breakthroughs and other important information from the Division of Pediatric Nephrology.
The baby was already in a medical crisis by the time Laurel K. Willig, MD, Pediatric Nephrologist at Children's Mercy Kansas City and Assistant Professor of Pediatrics at the University of Missouri-Kansas City, examined her. With her electrolytes severely out of balance and her kidneys failing, her tiny body swelled from edema and she struggled to breathe.
More than a decade ago, Children's Mercy nephrologists contributed to the development of a white paper outlining care recommendations for pediatric dialysis. With two recent publications, Children's Mercy is once again helping spearhead guidelines for optimal care of children requiring dialysis.
Children’s Mercy Kansas City is helping lead the transformation of care for children with chronic kidney disease (CKD) as one of two clinical coordinating centers for the Chronic Kidney Disease in Children (CKiD) study.
The hereditary link to renal diseases, such as polycystic kidney disease, has long been recognized in the medical community.
As a clinician and scientist, Tarak Srivastava, MD, a nephrologist at Children’s Mercy Kansas City, brings a unique perspective to his search for the cause of hyperfiltration injury.
As the Midwest Clinical Coordinating
Center for the NIH-funded Chronic Kidney Disease in Children (CKiD)
study, Children's Mercy Hospitals and Clinics in Kansas City is at
the center of improving treatment for kids with chronic kidney
As Director of the Children's Mercy Bone and Mineral Disorders Clinic, Uri S. Alon, MD, treats children with osteoporosis and all types of congenital and acquired metabolic bone disorders.
One of the most common issues in the progression of chronic kidney disease is the occurrence of hyperfiltration injury, which can take place when a patient's remaining functional nephrons attempt to compensate for lost ones by filtering more material.
In addition to serving as the co-principal investigator for the NIH-funded Chronic Kidney Disease in Children (CKiD) study, Children's Mercy's Division Director of Nephrology Bradley A. Warady, MD, is recognized nationally as a leader in pediatric dialysis, committed to developing advanced treatment methods for pediatric end-stage renal disease.
In recent years, the number of children in the U.S. diagnosed with kidney stones has grown significantly. Children's Mercy Hospitals and Clinics in Kansas City has seen a large increase in these patients and is leading research to determine the cause.
One of the primary areas of research in the NIH-funded Chronic Kidney Disease in Children (CKiD) study is cardiovascular disease (CVD), because of the significant impact this complication can have on the outcome of children with chronic kidney disease.